Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma

British Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 546-549

  Bonacci, R ^a   Gigliotti, A ^a   Baudin, E ^a   Wion Barbot, N ^b   Emy, P ^c   Bonnay, M ^a   Cailleux, A F ^a   Nakib, I ^d   Schlumberger, M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^d REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Adrenal cortical carcinoma; Cisplatin; Etoposide; Mitotane

Indexed keywords

ANTINEOPLASTIC ALKALOID; ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; ETOPOSIDE;

ADRENAL CORTEX CARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; MALE; NAUSEA; NEUROLOGIC DISEASE; PRIORITY JOURNAL; VOMITING;

EID: 0031827589     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.530     Document Type: Article

References (18)

1. Bertagna C and Orth DN (1981) Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 71: 855-875
2. Boven E, Vermorken JB, Van Slooten H and Pinedo HM (1984) Complete response of metastasized adrenal cortical carcinoma with o,p'DDD. Cancer 53: 26-29
3. Bukowski RM, Wolfe M, Levine HS, Crawford DE, Stephens RL, Gaynor E and Harker WG (1993) Phase II trial of mitotane and cisplatins in patients with adrenal carcinoma: a Southwest Oncology Group Study. J Clin Oncol 11: 161-165
4. Burgess MA, Legha SS and Sellin RV (1993) Chemotherapy with cis-platinum and etoposide (VP16) for patients with advanced adrenal cortical carcinoma (ACC) (abstract). Proc Am Soc Clin Oncol 12: 188
5. Chun HG, Yagoda A, Kemeny N and Watson RC (1983) Cisplatin for adrenal cortical carcinoma (letter). Cancer Treat Rep 67: 513-514
6. Didolkar MS, Bescher RA, Elias EG and Moore RH (1981) Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 47: 2153-2161
7. Haak HR, Hermans J, Van de Velde CJH, Lentjes EGWM, Goslings BM, Fleuren G-J and Krans HMJ (1994) Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 69: 947-951
8. Hesketh PJ, McCaffrey RP, Finkel HE, Larmon SS, Griffing GT and Melby JC (1987) Cisplatin-based treatment of adrenocortical carcinoma. Cancer Treat Rep 71: 222-224
9. Hutter Jr AM and Kayhoe DE (1966) Adrenal cortical carcinoma: results of treatment with o,p'DDD in 138 patients. Am J Med 41: 581-592
10. Icard P, Louvel A and Chapuis Y (1992) Survival rates and prognostic factors in adrenocortical carcinoma. World J Surg 16: 753-758
11. Jensen J, Pass H, Sindelar W and Norton JA (1991) Recurrent or metastatic disease in select patienis with adrenocortical carcinoma. Arch Surg 126: 457-461
12. Johnson DH and Greco FA (1986) Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP16). Cancer 58: 2198-2202
13. Lubitz JA, Freeman L and Okun R (1974) Treatment of inoperable adrenal cortical carcinoma with mitotane (o.p'DDD). Int Pharm 17: 86-93
14. Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, Laudat M-H, Louvel A, Chapuis Y, Blondeau P, Bonnin A and Bricaire H (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322: 1195-1201
15. Pommier RF and Brennan MF (1992) An eleven-year experience with adrenocortical carcinoma. Surgery 112: 963-971
16. Schlumberger M, Brugieres L, Gicquel C, Travagli JP, Droz JP and Parmentier C (1991) 5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma. Cancer 67: 2997-3000
17. Tattersall MH, Lander H, Bain B, Stocks AE, Woods RL and Fox RM (1980) Cisplatin treatment of metastatic adrenal carcinoma. Med J Aust 1: 419-421
18. Van Slooten H and Van Oosterom AT (1983) CAP (cyclophosphamide, doxorubicin, and cisplatin) regimen in adrenal cortical carcinoma. Cancer Treat Rep 67: 377-379